Treace John T. - 26 Aug 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Offer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John T. Treace
Issuer symbol
TMCI
Transactions as of
26 Aug 2022
Net transactions value
+$450,342
Form type
4
Filing time
29 Aug 2022, 09:00:21 UTC
Previous filing
24 Aug 2022
Next filing
01 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Purchase $450,342 +21,491 +0.39% $20.95 5,506,455 26 Aug 2022 Direct F1, F2
holding TMCI Common Stock 1,605,000 26 Aug 2022 By Spouse F3
holding TMCI Common Stock 1,471,250 26 Aug 2022 By Spouse as cotrustee of a trust dated Sept 30, 2020 F3
holding TMCI Common Stock 1,839,063 26 Aug 2022 As Trustee of a trust dated Sept 25, 2020 F4
holding TMCI Common Stock 408,816 26 Aug 2022 As Co-Trustee of a trust dated July 29, 2021 F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $20.9000 to $20.9600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F2 Includes 33,875 restricted stock units.
F3 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F4 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.